Ocugen, Inc. - Proxy Solicitation & Information Statement 2022

DEFA14A 1 tm2215277d5_defa14a.htm DEFA14A

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

x	Filed by the Registrant
¨	Filed by a Party other than the Registrant
Check the appropriate box:
¨	Preliminary Proxy Statement
¨	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨	Definitive Proxy Statement
x	Definitive Additional Materials
¨	Soliciting Material under §240.14a-12

OCUGEN, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):
x	No fee required
¨	Fee paid previously with preliminary materials
¨	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

This filing relates to the 2022 Annual Meeting of Stockholders of Ocugen, Inc. (the “Company”).

The following communication was made available by the Company on Twitter on June 1, 2022:

Have you voted? 🗳️ The $OCGN #AnnualMeeting is June 7 and voting is easy. By mail, phone or online, you can have your voice heard!

Field: Page; Sequence: 2; Options: Last

Field: /Page

AI assistant